RecruitingCancerLiver CirrhosisChronic Hepatitis
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Eligible age
18+ yrs
Accepts
All genders
Locations
4 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.
Sponsor: Helio Genomics
You may qualify if…
- ✓ 2.1.1 Age 18 years or older.
- ✓ 2.1.2 A diagnosis of cancer, cancer remission, benign disease (benign tumor, diabetes, liver cirrhosis, chronic hepatitis B or hepatitis C virus infection, Chronic obstructive pulmonary disease, etc.) or apparently healthy volunteers. .
You may not qualify if…
- ✕ 2.2.1 Patients that are unwilling or unable to sign the Informed Consent Form will be excluded.
- ✕ 2.2.2 Approximately 50 mL of blood will be drawn from participants within an 8-week period under this protocol. Patients that have already given 50 mL of blood within this time frame will be excluded.
Where it's recruiting
California
Redondo Beach
Minnesota
Coon Rapids · Fridley · Minneapolis
Tennessee
Memphis
Texas
Dallas · Richardson
Source: ClinicalTrials.gov · NCT05181826 · last updated 2026-07-10